Archive: 29/05/2012

New drug strategy attacks resistant leukemia and lymphoma

Scientists at the Dana-Farber/Children's Hospital Cancer Center have developed an anti-cancer peptide that overcomes the stubborn resistance to chemotherapy and radiation often encountered in certain blood cancers when the ...

Researchers develop new, safer method for making vaccines

While vaccines are perhaps medicine's most important success story, there is always room for improvement. Researchers at Oregon Health & Science University's Oregon National Primate Research Center (ONPRC) appear to have ...

Why do Scots die younger?

Life expectancy in Scotland is markedly lower compared to other European nations and the UK as a whole. But what are the reasons for this higher mortality? An explanatory framework, synthesising the evidence is published ...

After 25 years, World No Tobacco Day is making an impact

May 31 marks the 25th anniversary of World No Tobacco Day, but does the day really inspire anyone to think about quitting smoking? Yes it does, according to a new study led by investigators from the Informatics Program at ...

Cabazitaxel can offer an advantage in certain patients

Cabazitaxel (trade name: Jevtana) has been approved since March 2011 in men with metastatic prostate cancer who no longer respond to conventional therapy with hormone blockers and have already been pre-treated with the cytostatic ...

page 2 from 6